Lidocaine (injection): Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
'''''For patient information about Lidocaine Transdermal Patch, click <u>[[Lidocaine (patient information)|here]]'''''</u>.
'''''For patient information about Lidocaine Transdermal Patch, click <u>[[Lidocaine (patient information)|here]]'''''</u>.


'''''For patient information about Lidocaine Viscous (lye' doe kane), click <u>[[Lidocaine Viscous (patient information)|here]]'''''</u>.
'''''For patient information about Lidocaine Viscous (lye' doe kane), click <u>[[Lidocaine (patient information)|here]]'''''</u>.


{{SB}} XYLOCAINE
{{SB}} XYLOCAINE

Revision as of 16:17, 11 March 2014


Lidocaine
XYLOCAINE® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Lidocaine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

For patient information about Lidocaine Transdermal Patch, click here.

For patient information about Lidocaine Viscous (lye' doe kane), click here.

Synonyms / Brand Names: XYLOCAINE

Overview

Lidocaine xylocaine, or lignocaine (former BAN is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery.

Category

Anesthetic and Antiarrythmic

FDA Package Insert[1]

| Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages

Mechanism of Action

Lidocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (Na+) channels in the neuronal cell membrane that are responsible for signal propagation.[2] With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by stopping them before they begin. Careful titration allows for a high degree of selectivity in the blockage of sensory neurons, whereas higher concentrations will also affect other modalities of neuron signaling.

References

  1. "XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION [ASTRAZENECA LP]".
  2. Carterall, William A. (2001). "Sodium Channels and Neuronal Hyperexcitability". Novartis Foundation Symposia. 241: 206. doi:10.1002/0470846682.ch14. ISBN 9780470846681. |chapter= ignored (help)